• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Phar LLC

Partnership for Health Analytic Research, LLC

  • Services
    • Economic Modeling
    • Real World Data: Secondary Data Analysis
    • Evidence Synthesis
    • Real World Data: Primary Data Collection
  • Publications
  • Clients
  • Team
  • News
  • Contact

Primary Sidebar

News Categories

  • Presentations & Events
  • Awards & Recognition
  • Publications
  • News & Announcements

Archive

  • 2020
  • 2019
  • 2018
  • 2017

PHAR Presents Recommendations on Treating Primary Immune Thrombocytopenia at ASH 2020 Annual Meeting

Clinical guidance from a PHAR research study on how to taper thrombopoietin receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP) was presented at the 2020 American Society of Hematology Annual Meeting & Exposition. PHAR developed this important guidance with clinical experts using the RAND/UCLA modified Delphi panel process. The consensus statements presented could serve as a guide for clinical care by identifying patients who could safely taper and discontinue TPO-RAs and help to inform the design and development of future clinical trials. The study was also published in the December 2020 issue of Research and Practice in Thrombosis and Haemostasis. The presentation and manuscript can be found on our publications page.

December 17, 2020 | Presentations & Events, Publications

Partnership for Health Analytic Research, LLC

Beverly Hills
Cambridge
San Francisco
info@pharllc.com
310.858.9555
pharllc.com
  • Employment
  • Contact
Design by Studio Rainwater
© PHAR LLC 2021